prof. dr. H.J. (Hiddo) Lambers Heerspink

Areas of Interest and expertise include diabetes, nephrology, clinical pharmacology

Consultant to the following pharmaceutical companies: AstraZeneca, Alexion, Bayer, Boehringer Ingelheim, CSL Behring, Dimerix, Eli-Lilly, Gilead, Janssen, NovoNordisk, Novartis, Mitsubishi Tanabe, and Travere Therapeutics; Received research support for conducting clincial trials from AstraZeneca, Bayer, Boehringer Ingelheim, Janssen and NovoNordisk; Speaker services for AstraZeneca, Eli-Lilly and Novo Nordisk. Part-time position at The George Institute for Global Health and George Clinical.
Member scientific advisory board Dutch Diabetes Foundation
Grant review committees for the European Association for the study of Diabetes and American Diabetes Association